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Bipolar disorders are common psychiatric disorders that affect 1–5%of the populationworldwide.Major advances in
the epidemiology, pathophysiology, and treatment of the disorders have recently occurred. Themajority of published
reports, however, originate from the Western hemisphere, mostly Europe and the United States. There is a shortage
of data from the Arab world on bipolar disorders. In an era of globalization and rapid communication, it is not
clear to what extent research findings pertaining to one part of the world are by necessity applicable to other parts.
Psychiatric disorders are known to be affected by the culture in which they occur, and knowledge of variations in
illness presentation in different ethnic groups is also increasing. However, knowledge of variations affecting Arab
populations remains quite limited. This paper provides a critical review of the literature on bipolar affective disorders
in the Arab world, pointing to major gaps in knowledge and future opportunities to fill these gaps.
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Introduction
The Arab world is a loose association of countries
in the Middle East and North Africa that are con-
nected by history, language, and culture. The total
population exceeds 300 million people. The major-
ity of Arabs are Muslim, although there are also
large Muslim populations outside the Arab world
and there is a considerable number of Arabs who
are non-Muslim (e.g., Christian and Jewish). Wide
discrepancies exist in the economies of countries
such as the United Arab Emirates and Qatar, boast-
ing per capita incomes among the highest in the
world, and countries such as Djibouti and Soma-
lia, which have some of the poorest. Biomedical re-
search, particularly in the field of mental health,
is relatively weak, often stigmatized, and, in cer-
tain areas, almost nonexistent. Here, we provide a
brief overview of relevant research on bipolar dis-
orders in the Arab world, point out major gaps in
the literature, and offer some suggestions for future
research.
Literature review: bipolar patients in the
Arab world
Research on mental health in the Arab world
has been lagging behind, with a recent review
indicating that, over the last four decades,
mental health publications in the Arab world rep-
resented less than 1% of the total medical publica-
tions from this region.1 Furthermore, many Arab
journals are not listed in major biomedical search
engines, such as PubMed and PsycInfo, and there-
fore a literature search on a specific topic can be
challenging. For instance, a PubMed search us-
ing the keywords “bipolar disorder” and “Arab”
revealed only 25 publications, several of which
were irrelevant. A search using PsycInfo revealed
similar results. We therefore used several other
strategies in searching the literature, including a
search by Arab country (e.g., Egypt, Lebanon,
Tunisia, and Oman) and using specific search en-
gines for Arab countries, such asArabpsynet and the
Institute for Development, Research, Advocacy, and
Applied Care (IDRAAC). We also examined the
doi: 10.1111/nyas.12652
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references in key publications. The resulting sum-
mary of the identified relevant literature is cate-
gorized into three domains: epidemiology/clinical
manifestations, etiology/biological mechanisms,
and treatment/service utilization.
Epidemiology and clinical characteristics
A large part of the published literature in the Arab
world consists of epidemiological surveys, such as
that of mental disorders in an adult population
attending a primary healthcare setting in Qatar.2
This prospective cross-sectional survey of 1660
respondents involved a face-to-face interview us-
ing a “designed diagnostic screening question-
naire” consisting of 79 questions on symptoms and
signs of common mental health disorders. Follow-
ing completion of the self-administered question-
naire, a provisional diagnosis was made, which was
later confirmed by a psychiatrist using Diagnos-
tic and Statistical Manual of Mental Disorders IV
(DSM-IV) criteria. The results indicated that the
prevalence of bipolar disorder among the Qatari
population was 4.3%, which, interestingly, was
higher among female subjects (5.3%) compared to
males (3.1%). In a prospective study of all psychi-
atric admissions to a general hospital in an Eastern
province of Saudi Arabia between 1988 and 1998,3
a total of 1336 patients had 2217 admissions during
that period; 19.5%were diagnosedwith schizophre-
nia and 15.2% suffered from bipolar disorder.
The diagnoses were made using “a fully-structured
45-item questionnaire specifically designed for data
collection.” Between 1998 and 1993, the diagnosis
followed the DSM-IIIR criteria, and in 1993, the
criteria shifted to the International Classification of
Diseases 10 (ICD-10).
A more recent study estimated the prevalence of
mental disorders among 1682 school-aged Omani
adolescents and youth4 with face-to-face interviews
using the Composite International Diagnostic In-
terview (CIDI):5 13.9% had at least one DSM-IV
diagnosis. The prevalence was 3% for major de-
pressive disorder, 1% for bipolar disorder, and the
highest was 9% for any anxiety disorder, including
phobias. There were also data on mental health in
specific countries, such as Lebanon, from large
multinational surveys. The World Mental Health
Survey Initiative, for instance, provides the lifetime
prevalence of different mood disorders in Lebanon
as follows: major depression (10.9%), bipolar I
disorder (0.4%), bipolar II disorder (0.5%), bipo-
lar spectrum disorder (2.4%), and subthreshold
bipolar disorder (1.5%).6 The data from Lebanon
emerged from a population-based survey using the
World Health Organization (WHO) CIDI version
3.0, which was given to 2857 household members
and had diagnostic criteria that followed the DSM-
IV. Criteria for subthreshold hypomania included at
least one symptom ofmania with failure tomeet the
full diagnostic criteria for hypomania.
Furthermore, several publications addressed the
unipolar/bipolar dichotomy. For instance, Okasha
et al.,7 who estimated the frequency of bipolar
disorder among patients with a major depressive
episode in Egypt, found that 188 out of 302 (62%)
major depressive disorder patients could be diag-
nosed as bipolar using the Hypomania Checklist 32
(HCL-32) questionnaire.8 This compares with 42
out of 306 (14%) when the DSM-IV is used and
144 out of 302 (47%) when using other, less specific
definitions of bipolarity. Underreporting of bipolar
disorder was also found by a recent WHO multi-
national study9 of data from eight countries that
participated in the World Mental Health Survey
(n = 47,552), including Lebanon (n = 2857). The
results showed that many of the patients who were
screened out for bipolarity on the basis of the CIDI
could in fact be bipolar. The issue of bipolarity
was further investigated by researchers in Tunisia
who found that the polarity of the first episode
in bipolar disorder could predict the course of the
illness. In a retrospective study of 38 patients di-
agnosed with bipolar disorder in accordance with
DSM-IV-TR, a first episode of mania or hypo-
mania was associated with more frequent manic
episodes and substance use. A first episode of de-
pression, on the other hand,was predictive of amore
chronic course, characterized by more episodes of
depression with suicidal ideation and hypomania.10
Moreover, Douki et al. compared two samples of
bipolar patients (40 subjects each) in two distinct
geographical locations: Tunisia and France.11 All
patients met DSM-IV criteria for bipolar disorder.
The French patients were all from consecutive ad-
missions to Centre Hospitalier Le Vinatier in Lyon,
France, and the Tunisian patients were selected by
matching the French patients on the basis of gen-
der and duration of illness. The main difference
between the two groupswas the type of first episode:
mania in three-quarters of cases in Tunisia and
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depression in three-quarters of cases in France.
The same figures applied to the recurrences: more
mania in Tunisia and more depression in France.
Unipolar mania, although rarely mentioned in the
Western literature, was three times more common
in Tunisia than in France, according to these in-
vestigators. In a study by Dakhlaoui et al.12 that
followed 72 DSM-IV bipolar patients who were first
hospitalized at the Razi Hospital in Tunis between
1997 and 2001, recurrent mania and no episodes
of depression was called unipolar mania, and the
rest of the cases were called bipolar I. The authors
noted that compared topatientswithbipolar I, those
with unipolar mania had an earlier age of onset (23
years vs. 27.6 years). They were also less likely to use
substances and experienced less frequent affective
episodes.
A number of articles addressed the issue of
comorbidity of bipolar disorders. A retrospective
comorbidity study from Lebanon13 assessed all
patients hospitalized at the Psychiatric Unit of the
St. GeorgeHospital between 1979 and 1992. In 1643
charts available for review, 222 subjects (13.5%)met
DSM-IIIR criteria for substance abuse. Of these,
144 patients (64.9%) were found to have con-
comitant psychiatric diagnoses. The mean age of
onset of substance abuse was 25.9 ± 10.5 years
and the mean duration of abuse was 8.1 ± 8.5
years. Among patients with dual diagnoses, 42% of
cocaine abusers suffered from some form of bipo-
lar disorder, whereas 45% of cannabis abusers also
suffered from schizophrenia. Heroin users, how-
ever, were more likely to suffer a personality disor-
der, specifically antisocial personality. Furthermore,
Erfan and Amer14 assessed the prevalence of nico-
tine dependence among consecutive admissions to
a private hospital in Egypt. They limited their study
to patients with schizophrenia (n = 70) and bipo-
lar disorder (n = 46). They found that 58.6% of
the schizophrenic patients were smokers (60% were
dependent) compared to 32.6% of the bipolar
patients (38.5% were dependent). With respect
to medical comorbidity, Ezzaher et al.15 reported
that Tunisian bipolar patients were more likely to
be obese than controls (30% vs. 12%) and also
had higher cholesterol and low-density lipoprotein
(LDL) values and lower high-density lipoprotein
(HDL) values than controls. The specific role of
medications, such as valproic acid, in the treatment
of such comorbid conditions was not specified.
Etiology/pathophysiology
Compared to the literature addressing epidemi-
ology and/or clinical manifestations of bipolar
disorders in the Arab world, the literature dealing
with etiology and/or pathophysiology is even more
difficult to find. There were several studies that as-
sessed the effects of consanguinity onmental health.
As marriage between cousins is a common practice
and culturally accepted in this part of the world,16
it is not surprising that researchers assessed the
impact of consanguinity on different aspects of
mental health. For example, Saadat17 investigated
whether parental consanguineous marriages could
affect the age of onset of bipolar disorder in a
subject population of 195 bipolar disorder patients.
All patients were diagnosed in accordance with
DSM-IV criteria. The study found that the age
of onset was earlier for the offspring of con-
sanguineous marriages compared to unrelated
controls, but only for an age of onset above 25 years.
In two independent, systematic studies on the
rate of consanguinity among patients with bipolar
I disorder in Egypt, Mansour et al.18 compared
the rate of consanguinity among Egyptian bipolar
patients and appropriate controls. The first study
was a case–control study of 93 bipolar patients
diagnosed in accordance with DSM-IV criteria
and 90 screened controls. Consanguinity was
determined by self-report and confirmed by DNA
analysis. There were 34 parental consanguineous
marriages for the 93 bipolar patients (36.5%) and
only 16 parental consanguineous marriages for the
90 control subjects (17.7%), a difference that was
statistically significant (P < 0.005). The second
study was a community-based survey of psychiatric
morbidity that used the Mini International Neu-
ropsychiatric Interview (Arabic version).19 Out of
1584 subjects screened, 35 subjects were identified
as bipolar patients and 150 randomly selected,
unaffected subjects were identified as controls. The
rate of parental consanguinity was estimated by self-
report only. In this study, the corresponding figures
for parental consanguinity were 16 of 35 (45.7%)
for the bipolar patients and 23 of 150 (15.1%)
for the controls (P < 0.0001). In a later study, the
authors examined the possibility that the associ-
ation between increased risk of bipolar disorder
among consanguineous families could be mediated
by telomere length.20 They measured telomere
length in 108 bipolar patients and 114 matched
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controls and found no differences in telomere
length between the groups and no relation to
consanguinity.
There have also been reports of associations
between specific genetic polymorphisms and bipo-
lar I disorder in various Arab populations. In one
study, 79 patient–parents triads of bipolar patients
were analyzed in a Palestinian Arab population.21
Using the transmission disequilibrium test, the au-
thors stated that the results are “consistent with
previous reports of linkage between microsatellite
marker D22S278 and bipolar disorder.” Further-
more, in a study of 109 bipolar patients meeting
DSM-IV criteria and 110 controls in aTunisian pop-
ulation, a genotype analysis that was carried out by
multiplex polymerase chain reaction (PCR) showed
an association between the L55M and Q192R poly-
morphisms of paraoxonase 1 (PON1) and bipo-
lar I disorder.22 A recent study from Egypt fo-
cused on the association between the methylenete-
trahydrofolate reductase (MTHFR) polymorphism
and schizophrenia and bipolar disorders23 among
103 schizophrenic patients, 134 bipolar patients,
and 149 controls, with diagnoses made in accor-
dance with DSM-IV-TR criteria and using the
MINI. The authors found a higher prevalence
of the MTHFR C677T polymorphism in bipo-
lar patients and schizophrenia than in the healthy
controls. Another recent study investigated the
association of two genes encoding the enzyme
myo-inositol monophosphatase 1 (IMPA1) and
myo-inositol monophosphatase 2 (IMPA2) with
bipolar disorder. The sample consisted of 74 Pales-
tinian proband–parent trios, and all affected off-
spring (n = 92) met DSM-IV criteria for bipolar
disorders, using the SCID interview. The authors
reported a significant association between IMPA2
and bipolar disorder in the trio sample of Pales-
tinian Arabs.24 These studies, however, remain iso-
lated and suffer from relatively small numbers of
subjects. It is often unclear whether the studies were
sufficiently powered for statistical analyses. With a
database so small, we did not find any systematic
reviews or meta-analyses.
In addition to the genetic studies in bipolar
patients, there are biological reports on neuro-
chemical, neuroendocrine, or immune parameters.
One study from Morocco explored the effects of
fasting during Ramadan on the course of illness
in 20 lithium-treated patients with stable bipolar
disorder diagnosed in accordance with ICD-10
criteria.25 The authors reported a relapse rate of
45% during Ramadan in spite of adequate plasma
lithium concentrations. They attribute the relapse
to a change in “social rhythm.” Another study from
Tunisia investigated the presence of hyperhomocys-
teinemia in 92 DSM-IV–diagnosed bipolar disorder
patients and 170 controls, and attempted to relate
hyperhomocysteinemia to the 5,10-MTHFR C677T
polymorphism.26 They found a significant increase
in blood levels of homocysteine in bipolar disor-
der patients, but this change was independent of the
C677Tpolymorphism.They also found a significant
decrease in the blood levels of folic acid. The hyper-
homocysteinemia, they noted, was associated with
the duration of the depressive episode, whereas the
hypofolatemia was associated with lithium and/or
carbamazepine use.
In a different study also fromTunisia, the authors
assessed the variations in the activity of paraoxanase,
an enzyme associated with the synthesis of lipopro-
tein particles, and the lipid profile of 66 bipolar
disorder patients, diagnosed in accordance with
DSM-IV criteria, and 64 matched controls. Com-
pared to the controls, the patients had significantly
lowered paraoxanase activity and ApoA1 levels and
significantly higher total cholesterol, low-density
protein cholesterol (c-LDL) and lipoprotein (a) (Lp
(a)).15 The relation to the risk of cardiovascular
disease in these patientswas not assessed. Thepreva-
lence of obesity and overweight in Tunisian bipolar
patients was evaluated by the same group,27 who
studied 130 DSM-IV–diagnosed bipolar patients
and 130 matched controls. They found the preva-
lenceofobesity tobemuchhigher inbipolarpatients
(30.1%) compared to the controls (12.3%). The
observed increase in body mass index in the bipolar
patients was not related to gender or tobacco or
alcohol use, but could be associated with the use
of valproic acid. Furthermore, the presence of
immunological perturbations in bipolar disorder
patients was assessed by a group of Egyptian
investigators28 who compared the percentages of
lymphocytes, active T-lymphocytes, and natural
killer (NK) cells in 20 manic patients and 20
healthy controls. They found a significant decrease
in the percentage of lymphocytes and NK cells in
the manic group compared to controls; however,
the number of activated T-lymphocytes was not
changed. These data from the Middle East add to
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the growing world literature suggesting immune
and/or inflammatory changes in patients with
bipolar disorders.
Service utilization/treatment
Not surprisingly, quality research in the areas of ser-
vice utilization and treatment in the Arab world is
also scarce. Several reports address service utiliza-
tion in general as it relates to specific countries or
regions, reasons why patients are frequently non-
compliant with their medications, and patterns of
psychiatric hospitalizations. For example, Al Riyami
et al.29 conducted face-to-face interviews using the
CIDI with 1836 Omani school-aged children and
young adults between the ages of 14 and 23 years;
only 13.2% of patients with any DSM-IVmood dis-
ordermade treatment contact for their disorderdur-
ing the first year. For patients with bipolar disorder,
the median delay in initial treatment contact was
2 years, and male patients were significantly less
likely to make treatment contact than their female
counterparts. In addition, Bener et al.30 studied
reasons for medication noncompliance among 564
hospitalizedpsychiatric patientswhowere followed-
up in the outpatient clinic of a psychiatry depart-
ment in Doha, Qatar. Three-hundred twenty-eight
patients (58%)were consideredmedication compli-
ant, and the remaining 236 (41.8%)were considered
noncompliant; 12.7% of bipolar disorder patients
were noncompliant compared to a noncompliance
rate of 28.4% among schizophrenic patients. Rea-
sons for noncompliance included poor social super-
vision (40%), irregular clinic attendance (55.5%),
and a lack of education about medication (58.1%).
The authors strongly encouraged better health edu-
cation of patients at the community level.
Most reports that focus on treatment of bipolar
disorder in the Arab world tend to be general and
often consist of a simple description of the prod-
uct and its clinical usefulness as seen by the authors.
There are also occasional critical reviews of the topic
and informed opinions,31 as well as articles written
in favor of specific medications. It is therefore not
surprising that lithium gets the most attention in
this regard, as lithium is the treatment standard for
bipolar disorders. In a critical review by Abou Saleh
on the prediction of lithium response in patients
with affective disorders,32 it was concluded that
accuracy of the diagnosis, personality factors, and
early response remain the best predictors.33 Other
articles address issues such as lithiumclearance in an
Egyptian population34 and a new and accu-
rate method for predicting daily lithium dosage
requirements.35 There were also isolated reports on
other medications, such as the efficacy and safety
of risperidone in psychotic patients36 and the use
of clozapine as a mood stabilizer in chronic and
treatment-resistant bipolar disorder patients.37 We
were surprised by the near absence of results from
clinical trials taking place in the Arab world. As an
example, a search for “clinical trials” in the search
engine IDRAAC returned nine articles. On closer
examination, five of the studies were not conducted
in the Arab world, and the four others were review
articles written by Arab authors. Not a single paper
reported on results of randomized controlled tri-
als conducted in the Arab World on psychotropic
medications.
Critical assessment
This review revealed to us major gaps in the Arab
psychiatry literature in general and in the literature
on bipolar disorders specifically. One major prob-
lem in the literature search was the absence of rele-
vant search engines for the Arabicmedical literature
or in Arabic. Most psychiatric journals published
in the Arab world are not included in PubMed or
PsycInfo. There are regional search engines, such as
Arabpsynet and IDRAAC, but more work needs to
be done to improve their effectiveness in specific
literature searches.
The methodology sections in many manuscripts
published in the Arab psychiatry literature is su-
perficial and/or incomplete. Diagnostic criteria are
often mentioned but without the needed informa-
tion on the specific diagnostic tools used, the in-
dividuals making the diagnoses, or the training of
the personnel using diagnostic interviews. Further-
more, although many of these structured diagnos-
tic interviews are available in Arabic, information
about adaptation and validation in the local culture
is often lacking. The statistical analysis is rarely ade-
quately discussed, and very few reports address the
issue of statistical power and whether sample sizes
are adequate enough to answer the research ques-
tion; advanced statistical analyses are rare. In addi-
tion, the research question and the methods used to
address it are not always in harmony.
As to the research topics, most reported stud-
ies are observational and/or descriptive in nature.
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Limited epidemiological and clinical observations,
including case reports, are common; however, we
have not found large systematic analyses or meta-
analyses. Biological reports, including genetic stud-
ies, are frequently underpowered, and randomized
controlled drug trials are almost nonexistent. The
best studies with respect tomethodologies and stan-
dards seem to be those that are part of a regional or
multinational investigation (e.g., WHO studies), in
which an individual Arab country or countries take
part.6,7,9
Suggestions for the future
In view of the gaps addressed above, it seems rea-
sonable to continue and intensify efforts to trans-
late studies into Arabic and adapt and validate
representative andwidelyuseddiagnostic interviews
and psychiatric rating scales that should be used
routinely in all Arabic clinical reports; IDRAAC
in Lebanon has made significant efforts in this
regard.38 Access to these tools should also be made
easy for researchers to incorporate them in their
daily work.
Another priority should be serious epidemiologi-
cal work using the DSM-V39 and/or its global coun-
terpart ICD-11.40 The DSM-V has recently been
adopted by the American Psychiatric Association
after many years of hard work to capture the lat-
est knowledge about different psychiatric disorders.
The DSM-V also recognizes cultural variations for
many disorders and efforts to illustrate this section
with Arabic examples should be undertaken. Al-
though the ICD-11 is still in the final stages of its
development, it has incorporatedfield studies in dif-
ferent regionsof theworld to assess its use among the
local population. A group of clinicians representing
the Arab world has been actively engaged in this
endeavor.41 The group is tasked with making sug-
gestions and recommendations on the basis of field
studies conducted in various regions of the Arab
world. This area of research is therefore ready for se-
rious epidemiological work for the DSM-V and/or
the ICD-11 to be undertaken in Arab countries.
It is also very important for Arab investigators to
collaborateon largeprojects, suchas the genomicsof
affective disorders. Individual studies should have a
minimum set of requirements, such as standardized
and validated diagnostic criteria,38 state-of-the-art
sequencing procedures, and a large pool of patients
and controls. Most of the current genome-wide
association studies in psychiatric disorders have
been done on Western European populations;42
there are no sufficiently large samples of Arab pop-
ulations available to study in order to test such as-
sociations. It is to be anticipated that there will be
a combination of unique and overlapping genetic
variations among Arab bipolar disorder patients
relative to Western populations, but this remains
unknown at the present time. Large and systematic
collaborative efforts will be needed to establish sam-
ples that are ascertained and assessedusing common
diagnostic instruments and similar methodological
approaches. Similar approaches need to be followed
for randomized controlled trials in Arab countries
assessing the efficacy and safety of newer antide-
pressants and mood stabilizers. Only then will re-
search on bipolar disorders in the Arabworld be in a
position to advance science and contribute to a bet-
ter understanding of this disorder.
Conclusion
In many ways, bipolar disorder patients in the Arab
world are similar to bipolar patients in other regions
of theworld. For example, the reported prevalence is
in the range of 1–5%. The disorder can be found in
all countries, affecting both genders about equally,
and causing a great deal of distress and functional
impairment. It is when one looks more closely that
differences become more apparent. Specifically,
bipolar disorder patients in the Arab world suffer
from more frequent manic episodes, and there is
a higher rate of consanguinity among parents of
bipolar patients than among parents of controls.
Psychiatric comorbidity may not be as common,
particularly in relation to alcoholism and substance
abuse. Medical comorbidity, however, is frequent,
especially with obesity and themetabolic syndrome.
In summary, bipolar disorder in the Arab world
has features that directly overlap with those in other
regions, which provides the basis for comparison of
risk, susceptibility, and protective factors. However,
there are also unique features, such as consanguin-
ity and higher rates of mania, that provide the op-
portunity for a more focused approach that would
allow Arab researchers to make specific contribu-
tions to the field using data sets withmore standard-
ized methodologies and larger numbers of subjects.
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